Long-lasting clinical efficacy of allergen specific immunotherapy. (Q51723168)

10 April 2018

editorial

0 references

title

Long-lasting clinical efficacy of allergen specific immunotherapy. (English)

1 reference

10 April 2018

1 reference

Passalacqua G

1

1 reference

10 April 2018

Canonica GW

series ordinal

2

1 reference

10 April 2018

publication date

1 April 2002

1 reference

10 April 2018

published in

Allergy

1 reference

10 April 2018

volume

57

1 reference

10 April 2018

issue

4

1 reference

10 April 2018

page(s)

275-276

1 reference

10 April 2018

A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.03264.X

Allergic rhinitis and its impact on asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.03264.X

Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.03264.X

Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.03264.X

Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.03264.X

Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.03264.X

Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.03264.X

Long-term clinical efficacy of grass-pollen immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.03264.X

Long-term efficacy of preseasonal grass pollen immunotherapy in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.03264.X

Does the effect of immunotherapy last after termination of treatment? Follow-up study in patients with grass pollen rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.03264.X

7 January 2021

Persistence of efficacy after a brief course of polymerized ragweed allergen: a controlled study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.03264.X

7 January 2021

Long-term follow-up of patients treated with a three-year course of cat or dog immunotherapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.03264.X

7 January 2021

Long-term treatment with allergoid immunotherapy with Parietaria. Clinical and immunologic effects in a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.03264.X

7 January 2021

10.1034/J.1398-9995.2002.03264.X

Identifiers

DOI

1 reference

10 April 2018

release_jspv4pif6jbqvcxlufogvehs5q

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jspv4pif6jbqvcxlufogvehs5q

24 November 2022

mapped directly with Wikidata item

1 reference

10 April 2018